首页 > SCI期刊 > SCI期刊 > SCIE期刊 > 期刊先容
评估信息:
影响因子:2.012
《亚太临床肿瘤学杂志》(Asia-pacific Journal Of Clinical Oncology)是一本国际期刊。该刊由WILEY出书商创刊于2005年,刊期6 issues/year。该刊已被国际主要权势巨子数据库SCI、SCIE收录。
Asia–Pacific Journal of Clinical Oncology is a multidisciplinary journal of oncology that aims to be a forum for facilitating collaboration and exchanging information on what is happening in different countries of the Asia–Pacific region in relation to cancer treatment and care. The Journal is ideally positioned to receive publications that deal with diversity in cancer behavior, management and outcome related to ethnic, cultural, economic and other differences between populations. In addition to original articles, the Journal publishes reviews, editorials, letters to the Editor and short communications. Case reports are generally not considered for publication, only exceptional papers in which Editors find extraordinary oncological value may be considered for review. The Journal encourages clinical studies, particularly prospectively designed clinical trials.
《亚太临床肿瘤学杂志》是一本多学科的肿瘤学杂志,旨在成为一个增进协作和交换信息的服装论坛t.vhao.net,以领会亚太地域差别国度在癌症医治和照顾护士方面的环境。该杂志很是合适颁发与种族、文明、经济和其余人群差别有关的癌症行动、办理和功效多样性的出书物。除首创文章外,该杂志还颁发批评、社论、致编辑的信和冗长通信。病例报告凡是不斟酌颁发,只要编辑以为具备不凡肿瘤学代价的优异论文才可以或许被斟酌核阅。该杂志鼓动勉励临床研讨,特别是前瞻性设想的临床实验。
《Asia-pacific Journal Of Clinical Oncology》(亚太临床肿瘤学杂志)编辑部通信体例为Asia-Pac. J. Clin. Oncol.。若是您须要辅佐投稿或润稿办事,您可以或许征询咱们的客服教员。咱们专一于期刊征询办事十年,熟习颁发政策,可为您供给一对一投稿指点,防止您在投稿时频仍碰鼻,节流您的可贵时候,有用晋升颁发机率,确保SCI检索(检索不了全额退款)。咱们视诺言为生命,多方面确保文章宁静失密,在任何环境下都不会泄漏您的小我信息或稿件内容。
Gold OA文章占比 | 研讨类文章占比 | 文章自引率 |
-- | -- | -- |
开源占比 | 出书国人文章占比 | OA被援用占比 |
0.11... | 0.08 | 0.07... |
名词诠释:JCR分区在学术期刊评估、科研功效展现、科研标的目的指导和学术交换与协作等方面都具备主要的代价。经由过程对期刊影响因子的切确计较和详尽分别,JCR分区可以或许清楚地反应出差别期刊在统一学科范畴内的绝对地位,从而赞助科研职员精确辨认出高品质的学术期刊。
积年引文目标和发文量
2019-2021年国度/地域发文量统计
国度/地域 | 数目 |
Australia | 1151 |
CHINA MAINLAND | 147 |
USA | 106 |
Japan | 61 |
England | 54 |
South Korea | 38 |
Canada | 36 |
Singapore | 32 |
France | 28 |
Taiwan | 28 |
2019-2021年机构发文量统计
机构 | 数目 |
UNIVERSITY OF SYDNEY | 234 |
UNIVERSITY OF NEWCASTLE | 175 |
PETER MACCALLUM CANCER CENTER | 144 |
UNIVERSITY OF MELBOURNE | 109 |
UNIVERSITY OF NEW SOUTH WALES SYDNEY | 103 |
HUNTER MEDICAL RESEARCH INSTITUTE | 102 |
MONASH UNIVERSITY | 91 |
UNIVERSITY OF QUEENSLAND | 88 |
UNIVERSITY OF WESTERN AUSTRALIA | 77 |
CALVARY MATER NEWCASTLE HOSPITAL | 76 |
2019-2021年文章援用数据
文章援用称号 | 援用次数 |
Biomarkers and therapeutic advances in g... | 26 |
Metastatic triple negative breast cancer... | 17 |
Strain-specific probiotic (microbial cel... | 13 |
PD-L1 expression associated with worse s... | 13 |
Identifying the most prevalent unmet nee... | 13 |
The impacts of pretreatment circulating ... | 12 |
Cancer multidisciplinary team meetings i... | 11 |
Exosomal tetraspanins as regulators of c... | 10 |
Primary thromboprophylaxis (PTP) in ambu... | 10 |
Clinical response to apatinib monotherap... | 9 |
2019-2021年文章被援用数据
被援用期刊称号 | 数目 |
SUPPORT CARE CANCER | 24 |
ASIA-PAC J CLIN ONCO | 23 |
FRONT ONCOL | 23 |
BMC CANCER | 18 |
FUTURE ONCOL | 18 |
BMJ OPEN | 15 |
CANCERS | 15 |
COCHRANE DB SYST REV | 15 |
ONCOL LETT | 15 |
MEDICINE | 14 |
2019-2021年援用数据
援用期刊称号 | 数目 |
J CLIN ONCOL | 209 |
ANN ONCOL | 84 |
LANCET ONCOL | 80 |
INT J RADIAT ONCOL | 75 |
NEW ENGL J MED | 73 |
CANCER-AM CANCER SOC | 72 |
EUR J CANCER | 52 |
EUR UROL | 43 |
BRIT J CANCER | 41 |
LANCET | 37 |
若用户须要出书办事,请接洽出书商:Asia-Pac. J. Clin. Oncol.。